Second-line antiretroviral therapy: so much to be done

Lancet HIV. 2017 Oct;4(10):e424-e425. doi: 10.1016/S2352-3018(17)30112-1. Epub 2017 Aug 4.

Authors

Yibeltal Assefa¹, Charles F Gilks²

Affiliations

¹ School of Public Health, University of Queensland, QLD, Australia.
² School of Public Health, University of Queensland, QLD, Australia. Electronic address: c.gilks@uq.edu.au.

PMID: 28784425
DOI: 10.1016/S2352-3018(17)30112-1

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents
Anti-Retroviral Agents
Antiretroviral Therapy, Highly Active*
HIV Infections*
Humans
Treatment Failure
Viral Load

Substances

Anti-HIV Agents
Anti-Retroviral Agents